Skip to main content
Livermore
Livermore
ZHEN

Klingenstein Fields & Co LP

SEC CIK
0000859872
Latest filing
Aug 5, 2026

NVS holding history

Novartis AG in every 13F filed by Klingenstein Fields & Co LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overviewAll 13F holders of NVSFull Q2 2026 holdings

Shares (Q2 2026)
3,047
Value
$477.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVS by Klingenstein Fields & Co LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,047$477.5K<0.1%00.0%UnchangedHolders
Q1 20263,047$465.4K<0.1%00.0%UnchangedHolders
Q4 20253,047$420.1K<0.1%00.0%UnchangedHolders
Q3 20253,047$390.7K<0.1%−3,500−53.5%ReducedHolders
Q2 20256,547$792.3K<0.1%00.0%UnchangedHolders
Q1 20256,547$729.9K<0.1%−250−3.7%ReducedHolders
Q4 20246,797$661.4K<0.1%00.0%UnchangedHolders
Q3 20246,797$781.8K<0.1%00.0%UnchangedHolders
Q2 20246,797$723.6K<0.1%−246−3.5%ReducedHolders
Q1 20247,043$681.3K<0.1%−1,700−19.4%ReducedHolders
Q4 20238,743$882.8K<0.1%+500+6.1%AddedHolders
Q3 20238,243$839.6K<0.1%00.0%UnchangedHolders
Q2 20238,243$831.8K<0.1%00.0%UnchangedHolders
Q1 20238,243$758.4K<0.1%−985−10.7%ReducedHolders
Q4 20229,228$837.2K<0.1%−14−0.2%ReducedHolders
Q3 20229,242$702.0K<0.1%00.0%UnchangedHolders
Q2 20229,242$781.0K<0.1%+985+11.9%AddedHolders
Q1 20228,257$725.0K<0.1%−1,222−12.9%ReducedHolders
Q4 20219,479$829.0K<0.1%−291−3.0%ReducedHolders
Q3 20219,770$799.0K<0.1%+988+11.3%AddedHolders
Q2 20218,782$801.0K<0.1%−120−1.3%ReducedHolders
Q1 20218,902$761.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.